{"transactions":[{"id":3470947,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":156253,"kind":"person","name":"Walsh Robert F. III","position":1,"cik":"0001583727","reported_name":"Walsh Robert F. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Energy & Fine Chem."}}],"security":"Restricted Stock Units","published_at":"2019-07-02T23:13:41.000Z","date":"2019-06-30","kind":"exercise","acquired":false,"shares":14341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on April 9, 2019, and the remaining restricted stock units vest in three equal quarterly installments on each of September 30, 2019, December 31, 2019 and March 31, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on April 9, 2019, and the remaining restricted stock units vest in three equal quarterly installments on each of September 30, 2019, December 31, 2019 and March 31, 2020."}],"balance_after":43021,"derivative":{"underlying":"Common Stock","underlying_shares":14341},"source":{"system":"sec-edgar","filing":"0001123292-19-000966","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329219000966/edgar.xml","form_type":"4"}},{"id":3470946,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":156253,"kind":"person","name":"Walsh Robert F. III","position":1,"cik":"0001583727","reported_name":"Walsh Robert F. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Energy & Fine Chem."}}],"security":"Common Stock","published_at":"2019-07-02T23:13:41.000Z","date":"2019-07-01","kind":"sale","acquired":false,"shares":5007,"price":7.76,"value":38854.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units."}],"balance_after":28816,"source":{"system":"sec-edgar","filing":"0001123292-19-000966","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329219000966/edgar.xml","form_type":"4"}},{"id":3470945,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":156253,"kind":"person","name":"Walsh Robert F. III","position":1,"cik":"0001583727","reported_name":"Walsh Robert F. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Energy & Fine Chem."}}],"security":"Common Stock","published_at":"2019-07-02T23:13:41.000Z","date":"2019-06-30","kind":"exercise","acquired":true,"shares":14341,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."}],"balance_after":33823,"source":{"system":"sec-edgar","filing":"0001123292-19-000966","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329219000966/edgar.xml","form_type":"4"}},{"id":3557408,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":156253,"kind":"person","name":"Walsh Robert F. III","position":1,"cik":"0001583727","reported_name":"Walsh Robert F. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Energy & Fine Chem."}}],"security":"Restricted Stock Units","published_at":"2019-04-12T01:42:27.000Z","date":"2019-04-09","kind":"grant","acquired":true,"shares":57362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal quarterly installments beginning June 30, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal quarterly installments beginning June 30, 2019."}],"balance_after":57362,"derivative":{"underlying":"Common Stock","underlying_shares":57362},"source":{"system":"sec-edgar","filing":"0001123292-19-000629","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329219000629/edgar.xml","form_type":"4"}},{"id":3690556,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":156253,"kind":"person","name":"Walsh Robert F. III","position":1,"cik":"0001583727","reported_name":"Walsh Robert F. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Energy & Fine Chem."}}],"security":"Restricted Stock Units","published_at":"2019-01-22T23:07:46.000Z","date":"2019-01-04","kind":"grant","acquired":true,"shares":75758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"The number of derivative securities acquired was incorrectly reported as being disposed of in the report filed January 8, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning January 4, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning January 4, 2020."}],"balance_after":75758,"derivative":{"underlying":"Common Stock","underlying_shares":75758},"source":{"system":"sec-edgar","filing":"0001123292-19-000184","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329219000184/edgar.xml","form_type":"4/A","original_submission_date":"2019-01-08"}},{"id":3690555,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":156253,"kind":"person","name":"Walsh Robert F. III","position":1,"cik":"0001583727","reported_name":"Walsh Robert F. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Energy & Fine Chem."}}],"security":"Common Stock","published_at":"2019-01-22T23:07:46.000Z","date":"2019-01-04","kind":"grant","acquired":true,"shares":13774,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation."}],"balance_after":19482,"source":{"system":"sec-edgar","filing":"0001123292-19-000184","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329219000184/edgar.xml","form_type":"4/A","original_submission_date":"2019-01-08"}},{"id":3700027,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":156253,"kind":"person","name":"Walsh Robert F. III","position":1,"cik":"0001583727","reported_name":"Walsh Robert F. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Energy & Fine Chem."}}],"security":"Restricted Stock Units","published_at":"2019-01-09T01:05:48.000Z","date":"2019-01-04","kind":"grant","acquired":false,"shares":75758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 4, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 4, 2020."}],"balance_after":75758,"derivative":{"underlying":"Common Stock","underlying_shares":75758},"source":{"system":"sec-edgar","filing":"0001123292-19-000126","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329219000126/edgar.xml","form_type":"4"}},{"id":3700026,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":156253,"kind":"person","name":"Walsh Robert F. III","position":1,"cik":"0001583727","reported_name":"Walsh Robert F. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Energy & Fine Chem."}}],"security":"Common Stock","published_at":"2019-01-09T01:05:48.000Z","date":"2019-01-04","kind":"grant","acquired":true,"shares":13774,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation."}],"balance_after":19482,"source":{"system":"sec-edgar","filing":"0001123292-19-000126","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329219000126/edgar.xml","form_type":"4"}},{"id":3703701,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":156253,"kind":"person","name":"Walsh Robert F. III","position":1,"cik":"0001583727","reported_name":"Walsh Robert F. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Energy & Fine Chem."}}],"security":"Restricted Stock Units","published_at":"2019-01-04T23:46:22.000Z","date":"2019-01-02","kind":"exercise","acquired":false,"shares":9766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in three equal annual installments on each of January 2, 2020, 2021 and 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in three equal annual installments on each of January 2, 2020, 2021 and 2022."}],"balance_after":29297,"derivative":{"underlying":"Common Stock","underlying_shares":9766},"source":{"system":"sec-edgar","filing":"0001123292-19-000082","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329219000082/edgar.xml","form_type":"4"}},{"id":3703700,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":156253,"kind":"person","name":"Walsh Robert F. III","position":1,"cik":"0001583727","reported_name":"Walsh Robert F. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Energy & Fine Chem."}}],"security":"Common Stock","published_at":"2019-01-04T23:46:22.000Z","date":"2019-01-03","kind":"sale","acquired":false,"shares":4058,"price":7.0704,"value":28691.6832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units."}],"balance_after":5708,"source":{"system":"sec-edgar","filing":"0001123292-19-000082","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329219000082/edgar.xml","form_type":"4"}},{"id":3703699,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":156253,"kind":"person","name":"Walsh Robert F. III","position":1,"cik":"0001583727","reported_name":"Walsh Robert F. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Energy & Fine Chem."}}],"security":"Common Stock","published_at":"2019-01-04T23:46:22.000Z","date":"2019-01-02","kind":"exercise","acquired":true,"shares":9766,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."}],"balance_after":9766,"source":{"system":"sec-edgar","filing":"0001123292-19-000082","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329219000082/edgar.xml","form_type":"4"}},{"id":4104118,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":156253,"kind":"person","name":"Walsh Robert F. III","position":1,"cik":"0001583727","reported_name":"Walsh Robert F. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Energy & Fine Chem."}}],"security":"Restricted Stock Units","published_at":"2018-01-09T01:22:36.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":39063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning January 2, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning January 2, 2019."}],"balance_after":39063,"derivative":{"underlying":"Common Stock","underlying_shares":39063},"source":{"system":"sec-edgar","filing":"0001123292-18-000107","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356090/000112329218000107/edgar.xml","form_type":"4"}}]}